- Home
- SOL vs TLSA Comparison
SOL vs TLSA Comparison
Compare SOL & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- TLSA
- Stock Information
- Founded
- SOL 2005
- TLSA 2013
- Country
- SOL United States
- TLSA United Kingdom
- Employees
- SOL N/A
- TLSA N/A
- Industry
- SOL Semiconductors
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- SOL Technology
- TLSA Health Care
- Exchange
- SOL Nasdaq
- TLSA Nasdaq
- Market Cap
- SOL 109.2M
- TLSA 87.8M
- IPO Year
- SOL 2008
- TLSA 2000
- Fundamental
- Price
- SOL $2.00
- TLSA $0.90
- Analyst Decision
- SOL Buy
- TLSA
- Analyst Count
- SOL 3
- TLSA 0
- Target Price
- SOL $3.83
- TLSA N/A
- AVG Volume (30 Days)
- SOL 218.5K
- TLSA 384.7K
- Earning Date
- SOL 11-14-2024
- TLSA 12-27-2024
- Dividend Yield
- SOL N/A
- TLSA N/A
- EPS Growth
- SOL N/A
- TLSA N/A
- EPS
- SOL N/A
- TLSA N/A
- Revenue
- SOL $103,577,000.00
- TLSA N/A
- Revenue This Year
- SOL $44.70
- TLSA N/A
- Revenue Next Year
- SOL $20.53
- TLSA N/A
- P/E Ratio
- SOL N/A
- TLSA N/A
- Revenue Growth
- SOL 7.56
- TLSA N/A
- 52 Week Low
- SOL $1.41
- TLSA $0.41
- 52 Week High
- SOL $3.00
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- SOL 34.81
- TLSA 46.21
- Support Level
- SOL $2.00
- TLSA $0.88
- Resistance Level
- SOL $2.18
- TLSA $1.27
- Average True Range (ATR)
- SOL 0.15
- TLSA 0.10
- MACD
- SOL -0.06
- TLSA -0.00
- Stochastic Oscillator
- SOL 0.00
- TLSA 10.00
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.